Yingchao Cheng

Yingchao Cheng is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of RET inhibitors. With a total of 2 patents, his work focuses on innovative solutions for treating RET-related diseases.

Latest Patents

Yingchao Cheng's latest patents include advancements in RET inhibitors and pharmaceutical compositions. His inventions provide compounds that can be utilized in the treatment and prevention of various conditions, including cancer and irritable bowel syndrome. The patents detail a compound having Formula (I) or its various forms, including stereoisomers and prodrugs. These compositions are designed to be effective in the manufacture of medicaments aimed at alleviating symptoms associated with RET-related diseases.

Career Highlights

Cheng is currently associated with Sunshine Lake Pharma Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments that address significant health challenges.

Collaborations

Yingchao Cheng collaborates with esteemed colleagues such as Hongming Xie and Ming Luo. Their combined expertise enhances the research and development efforts at Sunshine Lake Pharma Co., Ltd.

Conclusion

Yingchao Cheng's contributions to pharmaceutical innovations, particularly in the area of RET inhibitors, demonstrate his commitment to advancing medical science. His work not only reflects his expertise but also his dedication to improving patient outcomes through innovative treatments.

Profile summary based on public USPTO records.